FIELD: organic chemistry, pharmacy. SUBSTANCE: invention proposes compounds of the general formula (I): where R1 means hydrogen, halogen atom, hydroxy-, nitro-, trifluoromethyl, C1-6-alkoxy-, aryl-C1-6-alkoxy-group, , C1-6-alkanoylamino--(CH2)n- or C1-6-alkylsulfonylamino--(CH2)n-group; R4 means hydrogen atom, C1-6-alkyl or aryl-C1-6-alkyl; R5 and R6 each independently means hydrogen atom or C1-6-alkyl or R5 and R6 in common with nitrogen atom to which they are bound form a ring; n = 0, 1 or 2; R2 and R3 each independently means hydrogen atom, C1-6-alkyl or benzyl or in common with nitrogen atom to which they are bound form pyrrolidino-, piperidino- or hexahydroazepino-ring, or its physiologically acceptable salts that can be used for treatment of state, for example migraine, where 5-HT1-like agonist is required. Also, invention describes new compounds of the formula (I), methods of their synthesis and pharmaceutical compositions containing thereof. EFFECT: improved methods of synthesis and treatment. 19 cl, 32 ex
Title |
Year |
Author |
Number |
CONDENSED INDOLE DERIVATIVE OR ITS PHARMACEUTICALLY ACCEPTABLE SALT, PHARMACEUTICAL COMPOSITION SHOWING ACTIVITY OF 5-$$$-RECEPTOR ANTAGONIST |
1993 |
- Lehrami Mehri Gaster[Gb]
- Pol Adrian Vajman[Gb]
|
RU2104279C1 |
HETEROCYCLIC COMPOUNDS AS ANTAGONISTS OF 5-HT RECEPTORS, METHOD OF SYNTHESIS, PHARMACEUTICAL COMPOSITION |
1992 |
- Frehnsis Dehvid King
- Ljarami Mari Gaster
- Kit Rajmond Malkholland
- Shirli Katrin Rakhman
- Pol' Adrian Viman
- Gehret Dzhon Zangen
- Kej Alison Uordl
- Gordon Smit Bakster
- Gaj Ehntoni Kennet
- Al'Berto Khulio Kauman
|
RU2124512C1 |
6-(SUBSTITUTED METHYLENE)PENEMS, METHOD OF PREPARING THEREOF, INTERMEDIATE PRODUCTS, AND PHARMACEUTICAL COMPOSITION |
1993 |
- Najdzhel Dzhon Perrimen Brum
- Frehnk Peter Kharrington
|
RU2133750C1 |
QUINOLINE DERIVATIVES AS TECHYCHININ NK RECEPTOR ANTAGONISTS |
1995 |
- Karlo Farina
- Dzhuzeppe Arnal'Do Maria Dzhardina
- Mario Grun'I
- Luka Franchesko Ravelija
|
RU2155754C2 |
METHOD OF PREPARING AND/OR PURIFYING CLAVULANIC ACID OR PHARMACEUTICALLY ACCEPTABLE SALTS OR ESTERS THEREOF CLAVULANIC ACID SALT WITH AMINO ACID |
1993 |
- Majkl Allen Kuk[Gb]
- Robert Bennett Uilkins[Gb]
|
RU2105768C1 |
DERIVATIVES OF 4-CYANO-4-PHENYLSUBSTITUTED CYCLOHEXANES OR CYCLOHEXENES, PHARMACEUTICAL COMPOSITION (VARIANTS), METHOD OF INHIBITION OF PHOSPHODIESTERASE ACTIVITY AND TUMOR NECROSIS FACTOR |
1993 |
- Zigfrid Benzhamin Kristensen Iv
|
RU2136656C1 |
HETEROCYCLIC COMPOUND OR ITS TAUTOMERIC FORM AND/OR PHARMACEUTICALLY ACCEPTABLE SALT AND/OR PHARMACEUTICALLY ACCEPTABLE SOLVATE, PHARMACEUTICAL COMPOSITION DECREASING BLOOD GLUCOSE LEVEL, METHOD OF TREATMENT AND/OR PROPHYLAXIS OF HYPOGLYCEMIC PATIENTS |
1993 |
- Dehvid Khej
- Dzhon Tomas Sajm
|
RU2134686C1 |
METHOD OF EPOXIDATION OF PROCHIRAL OLEFIN |
1995 |
- Bell Dehvid
- Finnej Frantsiska
- Attrill Robin Patrik
- Miller Dehvid
- Terner Dzhillian
|
RU2204562C2 |
SUBSTITUTED THIAZOLIDINEDIONE AND METHOD OF PREPARING THEREOF |
1993 |
- Kolin Ripli Pul
- Robin Shervud Roman
- Mal'Kol'M Dehvid Brajvell
- Alan Uil'Jam Tremper
|
RU2128179C1 |
METHOD OF SYNTHESIS OF CLAVULANIC ACID OR ITS PHARMACEUTICALLY ACCEPTABLE SALTS AND ETHERS, CLAVULANIC ACID SALT WITH AMINE |
1995 |
- Majkl Allen Kuk[Gb]
- Robert Bennett Uilkins[Gb]
|
RU2081121C1 |